These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4199490)

  • 21. [In vitro antibacterial effect of sulfamoxole/trimethoprim and sulfamethoxazole/trimethoprim].
    Hingst V; Sonntag HG
    Med Welt; 1979 Aug; 30(33):1199-201. PubMed ID: 491915
    [No Abstract]   [Full Text] [Related]  

  • 22. Selective elimination of Enterobacteriaceae from the digestive tract in rats with trimethoprim.
    Koopman JP; Kennis HM; Stadhouders AM; de Boer H; Hectors MP
    Z Versuchstierkd; 1985; 27(3-4):143-8. PubMed ID: 4050161
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of ampicillin and pivampicillin on the intestinal flora of man].
    Knothe H; Lembke U
    Zentralbl Bakteriol Orig A; 1973 Mar; 223(2):324-32. PubMed ID: 4145839
    [No Abstract]   [Full Text] [Related]  

  • 24. The action of trimethoprim-sulphamethoxazole against urinary pathogens.
    Smith DD; Bell SM; Levey JM; Loy YT
    Med J Aust; 1972 Feb; 1(6):263-5. PubMed ID: 4552261
    [No Abstract]   [Full Text] [Related]  

  • 25. [Sensitivity of enterobacteriaceae to sulfamethoxazole (SMZ), trimethoprim (TMP) and cotrimexazole (SMZ plus TMP)].
    Lynch B; Valenzuela MC; Donoso E; Cofre J; Vilches A; Aguero ME
    Rev Chil Pediatr; 1975; 46(1):17-9. PubMed ID: 1178944
    [No Abstract]   [Full Text] [Related]  

  • 26. Sensitivity of different Pseudomonas species and Aeromonas hydrophila to trimethoprim and sulfamethoxazole separately and in combination.
    Nord CE; Wadström T; Wretlind B
    Med Microbiol Immunol; 1974; 160(1):1-7. PubMed ID: 4214032
    [No Abstract]   [Full Text] [Related]  

  • 27. [Present status of the resistance of enterobacteria to the combination of a sulfonamide and trimethoprim].
    Riou B; Richard C; Rimailho A; Bottineau G; Coquin Y; Auzepy P
    Presse Med; 1984 Jun; 13(26):1637-8. PubMed ID: 6234571
    [No Abstract]   [Full Text] [Related]  

  • 28. Sulphamethoxazole-trimethoprim: effect on antibody response in man.
    Arvilommi H; Vuori M; Salmi A
    Chemotherapy; 1976; 22(1):37-42. PubMed ID: 1253629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of co-trimoxazole on faecal enterobacteria: no emergence of resistant strains.
    Moorhouse EC; Farrell W
    J Med Microbiol; 1973 May; 6(2):249-52. PubMed ID: 4575275
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of cefoperazone therapy on fecal flora.
    Mulligan ME; Citron DM; McNamara BT; Finegold SM
    Antimicrob Agents Chemother; 1982 Aug; 22(2):226-30. PubMed ID: 6927284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Synergism of trimethoprim and sulfamethoxazole action on microorganisms isolated from persons with urinary tract infections].
    Ganczarski A; Augustyniak B; Kloczkowski K; Prelich A; Stapor K
    Med Dosw Mikrobiol; 1972; 24(4):307-14. PubMed ID: 4632270
    [No Abstract]   [Full Text] [Related]  

  • 32. Co-trimaxazole therapy: place and prospects.
    O'Grady FW
    Med J Aust; 1973 Jun; 1(2):Suppl:19-25. PubMed ID: 4199528
    [No Abstract]   [Full Text] [Related]  

  • 33. Letter: Susceptibility of Bacteroides fragilis to co-trimoxazole.
    Okubadejo OA
    Lancet; 1974 May; 1(7865):1061. PubMed ID: 4133750
    [No Abstract]   [Full Text] [Related]  

  • 34. On the sensitivity of pseudomonas and proteus to the combination of trimethoprim and sulphamethoxazole.
    Ritzerfeld W; Hasch B
    Chemotherapy; 1972; 17(5):348-55. PubMed ID: 4205551
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination].
    Renzini G; Ravagnan G; Bormioli P; D'Alessandro A
    Antibiotica; 1969 Dec; 7(4):250-68. PubMed ID: 5004706
    [No Abstract]   [Full Text] [Related]  

  • 36. Therapeutic progress: trimethoprim-sulfamethoxazole.
    Ruiz López R; Saavedra S; Ramírez-Ronda CH
    Bol Asoc Med P R; 1984 Jul; 76(7):309-13. PubMed ID: 6332635
    [No Abstract]   [Full Text] [Related]  

  • 37. Selective intestinal decontamination of the digestive tract for infection prophylaxis in severely burned patients.
    Manson WL; Westerveld AW; Klasen HJ; Sauër EW
    Scand J Plast Reconstr Surg Hand Surg; 1987; 21(3):269-72. PubMed ID: 2831622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trimethoprim-sulfamethoxazole.
    Rubin RH; Swartz MN
    N Engl J Med; 1980 Aug; 303(8):426-32. PubMed ID: 6967184
    [No Abstract]   [Full Text] [Related]  

  • 39. Alterations in the sensitivity pattern after use of trimethoprim-sulfamethoxazole for two years in the treatment of urinary tract infections.
    Fruensgaard K; Korner B
    Chemotherapy; 1974; 20(2):97-101. PubMed ID: 4210895
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of trimethoprim-sulfamethoxazole on the renal excretion of creatinine in man.
    Berglund F; Killander J; Pompeius R
    J Urol; 1975 Dec; 114(6):802-8. PubMed ID: 1195454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.